Trump is meeting with pharmaceutical companies who are actively working to develop the COVID-19 vaccine.
The press office sends these details on the president’s upcoming meeting with coronavirus stakeholders:
Today, President Donald J. Trump will meet with pharmaceutical companies who are actively working to develop the COVID-19 vaccine to discuss how the United States Federal Government can help accelerate vaccine development.
The Trump Administration continues its whole-of-government approach to combatting the spread of coronavirus because the safety of the American people remains the highest priority for President Trump.
The following individuals are expected to attend:
The White House
President Donald J. Trump
Vice President Mike Pence
Mick Mulvaney, Acting White House Chief of Staff
Chris Liddell, Assistant to the President and Deputy Chief of Staff for Policy Coordination
Kellyanne Conway, Assistant to the President and Senior Counselor
Marc Short, Assistant to the President and Chief of Staff to the Vice President
Larry Kudlow, Assistant to the President and Director of the National Economic Council
Joseph Grogan, Assistant to the President and Director of the Domestic Policy Council
Tim Pataki, Deputy Assistant to the President and Director of the Office of Public Liaison
Ambassador Debbie Brix, White House Corona Virus Response Coordinator
Secretary Alex Azar, Department of Health and Human Services
Dr. Robert Redfield, Director, Centers for Disease Control and Prevention
Dr. Anne Schuchat, Principal Deputy Director, Centers for Disease Control and Prevention
Dr. Stephen Hahn, Commissioner of Food and Drugs, Food and Drug Administration
Dr. Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases
Executives of Pharmaceutical Companies
Emma Walmsley, CEO, GlaxoSmithKline
Dr. J. Joseph Kim, CEO, Inovio Pharmaceuticals
Stéphane Bancel, CEO, Moderna
Dr. Leonard Schleifer, CEO, Regeneron Pharmaceuticals
Stan C. Erck, CEO, President, and Director, Novorax
Daniel Menichella, CEO, CureVac
David O’Day, Chairman of the Board of Directors and CEO, Gilead
Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson and Johnson
Dr. Mikael Dolsten, Chief Scientific Officer and President Worldwide Research, Development and Medical, Pfizer Inc.
John Shiver, Senior Vice President, Global Vaccine Research and Development, Sanofi